Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide vs Diquafosol for Perioperative Dry Eye Management in Cataract Surgery
NCT07397949Phase 4Not yet recruiting
- Sponsor
- Samsung Medical Center
- Start
- Mar 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rebamipide ophthalmic solution in dry eye disease (DED), sponsored by Samsung Medical Center. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
rebamipide ophthalmic solution
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07397949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07397949.